The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
107516426 10751642 6 F 20150126 20160907 20150130 20160914 EXP US-PFIZER INC-2015042374 PFIZER 72.00 YR F Y 81.00000 KG 20160914 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
107516426 10751642 1 PS LYRICA PREGABALIN 1 Oral 300 MG, 2X/DAY N 21446 300 MG CAPSULE, HARD BID
107516426 10751642 2 SS LYRICA PREGABALIN 1 Oral 600 MG, DAILY N N17638 21446 600 MG CAPSULE, HARD
107516426 10751642 3 SS LYRICA PREGABALIN 1 300 MG, DAILY N 21446 300 MG CAPSULE, HARD
107516426 10751642 4 SS LYRICA PREGABALIN 1 Oral 150 MG, 3X/DAY N 21446 150 MG CAPSULE, HARD TID
107516426 10751642 5 C METFORMIN METFORMIN HYDROCHLORIDE 1 500 MG, 2X/DAY 0 500 MG BID
107516426 10751642 6 C AMLODIPINE BESILATE AMLODIPINE BESYLATE 1 5 MG, 1X/DAY 0 5 MG TABLET QD
107516426 10751642 7 C LOSARTAN/HCTZ HYDROCHLOROTHIAZIDELOSARTAN 1 1 DF, DAILY [HYDROCHLOROTHIAZIDE: 25MG]/[LOSARTAN POTASSIUM: 100MG] 0 1 DF TABLET
107516426 10751642 8 C LEVOTHYROXINE. LEVOTHYROXINE 1 0.175 MG, 1X/DAY 0 .175 MG QD
107516426 10751642 9 C SIMVASTATIN. SIMVASTATIN 1 20 MG, 1X/DAY (ONE TABLET, IN EVENING) 0 20 MG TABLET QD
107516426 10751642 10 C HYDROCODONE BITARTRATE AND ACETAMINOPHEN ACETAMINOPHENHYDROCODONE BITARTRATE 1 UNK, UP TO 4X/DAY 0 QID
107516426 10751642 11 C HYDROCODONE BITARTRATE AND ACETAMINOPHEN ACETAMINOPHENHYDROCODONE BITARTRATE 1 0
107516426 10751642 12 C AMITRIPTYLINE AMITRIPTYLINE 1 UNK, 1X/DAY (AT NIGHT) 0 QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
107516426 10751642 1 Neuropathy peripheral
107516426 10751642 2 Neuralgia
107516426 10751642 5 Diabetes mellitus
107516426 10751642 6 Blood pressure abnormal
107516426 10751642 7 Blood pressure abnormal
107516426 10751642 8 Thyroid disorder
107516426 10751642 10 Back pain
107516426 10751642 11 Neck pain

Outcome of event

Event ID CASEID OUTC COD
107516426 10751642 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
107516426 10751642 Drug ineffective
107516426 10751642 Fall
107516426 10751642 Joint injury
107516426 10751642 Lung disorder
107516426 10751642 Malaise
107516426 10751642 Pain in extremity
107516426 10751642 Thrombosis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found